Clinical Genomics Market is Expected to See a Growth of 16.8% During the Forecast Period | Exclusive Report by IMIR Market Research

Global Clinical Genomics Market size was valued at USD 719.01 million in 2021 and is projected to reach USD 1826.11 million by 2028, growing at a CAGR of 16.8% from 2021 to 2028 according to a new report by Intellectual Market Insights Research.

Get Sample Report: https://www.intellectualmarketinsights.com/download-sample/IMI-003645

Scope of Clinical Genomics Market Report:
A recent market research report added to repository of Intellectual Market Insights Research is an in-depth analysis of Global Clinical Genomics Market. On the basis of historic growth analysis and current scenario of Clinical Genomics market place, the report intends to offer actionable insights on global market growth projections. Authenticated data presented in report is based on findings of extensive primary and secondary research. Insights drawn from data serve as excellent tools that facilitate deeper understanding of multiple aspects of global Clinical Genomics market. This further helps users with their developmental strategy.

This report examines all the key factors influencing growth of global Clinical Genomics market, including demand-supply scenario, pricing structure, profit margins, production and value chain analysis. Regional assessment of global Clinical Genomics market unlocks a plethora of untapped opportunities in regional and domestic market places. Detailed company profiling enables users to evaluate company shares analysis, emerging product lines, pricing strategies, innovation possibilities and much more.

The report covers the all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers.

Clinical Genomics Market Players Analysis:
Quest Diagnostics Incorporated (U.S.)
Eurofins Scientific SE (Luxembourg)
Illumina, Inc. (U.S.)
PerkinElmer, Inc. (U.S.)
NeoGenomics Inc. (U.S.)
Foundation Medicine, Inc. (U.S.)
Rosetta Genomics Ltd. (Israel)
Invitae Corporation (U.S.)
Myriad Genetics, Inc. (U.S.)
Natera, Inc. (U.S.)
Genomic Health, Inc. (U.S.)
OPKO Health, Inc. (U.S.)
Centogene AG (Germany)
Clinical Genomics Pty Ltd. (Australia)
23andMe, Inc. (U.S.)
Iverson Genetic Diagnostics, Inc. (U.S.)
Veritas Genetics (U.S.),
Gene by Gene, Ltd. (U.S.),
GenomeDx Biosciences, Inc. (Canada),
MedGenome (India)
Strand Life Sciences Pvt. Ltd. (India)
Beijing Genomics Institute (BGI) (China)
Retrogen, Inc. (U.S.),
Personalis, Inc. (U.S.)
PathGroup (U.S.)

Clinical Genomics Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2021-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Clinical Genomics Market Segmentation Analysis:

By Product Type
Instruments
Consumables & Reagents
Services

By Application
Diagnostics
Newborn Screening
Genetics
Carrier Screening
Prenatal Screening
Others

By Test Type
Molecular Tests
Chromosomal Tests
Biochemical Tests

By End-user
Hospitals & Clinics
Government Laboratories & Research Centers
Academic & Research Institutes
Others

Full Access: https://www.intellectualmarketinsights.com/report/clinical-genomics-market-growth-and-trends/imi-003645

𝐒𝐨𝐦𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐤𝐞𝐲 𝐪𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐬𝐜𝐫𝐮𝐭𝐢𝐧𝐢𝐳𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐬𝐭𝐮𝐝𝐲 𝐚𝐫𝐞:

What are some of the recent brand building activities of key players undertaken to create customer value in the Clinical Genomics market?

Which companies are expanding litany of products with the aim to diversify product portfolio?

Which companies have drifted away from their core competencies and how have those impacted the strategic landscape of the Clinical Genomics market?

Which companies have expanded their horizons by engaging in long-term societal considerations?

Which firms have bucked the pandemic trend and what frameworks they adopted to stay resilient?

What are the marketing programs for some of the recent product launches?

Follow Us: LinkedIn

Mr. Smit Patel
Phone: +1 412-730-2889
Email: Smit@intellectualmarketinsights.com
Corporate Sales: Sales@intellectualmarketinsights.com

About US:

IMIR® Market Research Pvt Ltd.
Intellectual Market Insights Research is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including, Semiconductor, aerospace, Automation, Agriculture, Food & Beverages, Automotive, Chemicals and Materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports.

IMIR has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

This release was published on openPR.